缺氧与肺癌中获得的对免疫检查点抑制剂的耐药性有关
相关实验视频
Updated: Jun 6, 2025

07:01
Induction and Testing of Hypoxia in Cell Culture
Published on: August 12, 2011
84.7K
Camila Robles-Oteíza1, Katherine Hastings2, Jungmin Choi3,4
1Department of Immunobiology, Yale School of Medicine, New Haven, CT, USA.
The Journal of experimental medicine
|November 25, 2024
概括
低氧驱动非小细胞肺癌 (NSCLC) 免疫检查点抑制剂 (ICI) 的获得性耐药性. 向缺氧可以克服对ICI的抵抗,为NSCLC患者提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 免疫检查点抑制剂 (ICI) 是非小细胞肺癌 (NSCLC) 的确立治疗方法.
- 很大一部分NSCLC患者对ICI没有反应,许多最初反应的人会发展成获得性耐药性 (AR).
- 了解AR的机制对于改善NSCLC中的ICI疗效至关重要.
研究的目的:
- 确定非小细胞肺癌 (NSCLC) 免疫检查点抑制剂 (ICI) 获得性耐药性 (AR) 的新型驱动因素.
- 研究瘤微环境,特别是缺氧在ICI耐药性中的作用.
- 探索针对低氧的治疗策略,以克服NSCLC中的AR.
主要方法:
- 产生对抗PD-1和抗CTLA-4疗法的AR呈现的小鼠Msh2淘汰 (KO) 肺瘤.
- 对免疫细胞透,MHC-I/II表达和耐药瘤中缺氧特征的分析.
- 单细胞转录分析,以确定与缺氧相关的基因表达模式.
- 用低氧激活的前药物与ICI结合治疗小鼠模型.
主要成果:
- 耐药瘤显示T细胞透率降低,癌细胞内在MHC-I和MHC-II水平降低.
- 在耐药瘤中发现了广泛的缺氧区域.
- 低氧特征与ICI治疗的NSCLC患者无进展生存率降低相关.
- 在小鼠模型中,用低氧激活的前药物向低氧,延迟了对ICI的AR.
结论:
- 瘤缺氧是非小细胞肺癌中获得免疫检查点抑制剂耐药性的重要驱动因素.
- 向瘤代谢特征,如缺氧,与ICI结合,代表了一个有前途的治疗策略.
- 这项研究为开发新型组合疗法以克服NSCLC中ICI耐药性的发展提供了理由.
相关概念视频
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Hypoxia
934
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
934
Acute Respiratory Failure-II
174
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
174
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Respiratory Assessment: Purpose and Indications
1.0K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.0K

